Search

everythinglearnresearchcommunity

for

Search:↓

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

The HCR gene contributes to psoriasis risk.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

The new cocrystal KET-PABA is a more effective and safe anti-inflammatory treatment for skin conditions in mice.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Five FDA-approved drugs may help block COVID-19 virus entry.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Certain antiparasitics and antidepressants show promise for treating cryptococcosis, especially when combined with fluconazole.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

Astressin-B can reverse and prevent hair loss in stressed mice.

Cadd4 effectively reduces cholesterol levels without side effects.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.